
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
CNN
The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment.
The drug was developed for patients with mild cognitive impairment, not severe dementia, and intended to slow progression of Alzheimer's disease -- not just ease symptoms. The FDA has not approved a new Alzheimer's drug in nearly 20 years.
Jeffrey Epstein survivors are slamming the Justice Department’s partial release of the Epstein files that began last Friday, contending that contrary to what is mandated by law, the department’s disclosures so far have been incomplete and improperly redacted — and challenging for the survivors to navigate as they search for information about their own cases.

The Providence mayor wants the Reddit tipster to get a $50,000 FBI reward. It might not be so simple
His detailed tip helped lead investigators to the gunman behind the deadly Brown University shooting – but whether the tipster known only as “John” will ever receive the $50,000 reward offered by the FBI is still an open question.











